3//SEC Filing
VERIDIEN CORP 3
Accession 0001209191-07-029078
CIK 0001064011operating
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:00 PM ET
Size
12.9 KB
Accession
0001209191-07-029078
Insider Transaction Report
Form 3
VERIDIEN CORPVRDE
Cancellara Kenneth C
DirectorExecutive Chairman
Holdings
- 2,233,000(indirect: Owned by Lexxec Corporation of which Mr. Cancellara is an Officer and Director)
Common Stock
- (indirect: Owned by Lexxec Corporation of which Mr. Cancellara is an Officer and Director)
Options
Exercise: $0.06From: 2007-05-08Exp: 2012-05-08→ Common Stock (14,200,000 underlying) - 6,666,667
Common Stock
- (indirect: Owned by Lexxec Corporation of which Mr. Cancellara is an Officer and Director)
Preferred Stock > Series 2006-A (50,944 shares)
Exercise: $0.04→ Common Stock (14,569,984 underlying) Options
Exercise: $0.06From: 2007-05-08Exp: 2012-04-01→ Common Stock (2,500,000 underlying)
Footnotes (11)
- [F1]Options related to provision of Consulting Services
- [F10]Preferred Stock > Series 2006-A converts at 1:286 into common stock ($0.035 equivalent conversion price)
- [F11]Shares issued November 2006 - No expiry date on conversion option
- [F2]Exercise Price is $0.06 per share
- [F3]Exercise Price is $0.10 per share
- [F4]Vest on December 31, 2008 if Consulting Services are still being provided to Veridien
- [F5]Exercise Price is $0.10 per share
- [F6]Vest on December 31, 2009 if Consulting Services are still being provided to Veridien
- [F7]Options related to purchase by Veridien of 49.9% interest in Santius LifeSciences
- [F8]Exercise Price is $0.06 per share
- [F9]Exercise Price is $0.10 per share
Documents
Issuer
VERIDIEN CORP
CIK 0001064011
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001064011
Filing Metadata
- Form type
- 3
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:00 PM ET
- Size
- 12.9 KB